ampelopsin has been researched along with Injury, Myocardial Reperfusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; Meng, F; Qu, D; Wang, D; Xu, M; Zhang, X; Zheng, Q | 1 |
| Li, Y; Qi, X; Sun, X; Wei, L; Xu, Y; Zhang, Y | 1 |
| Ai, Q; Feng, K; Li, Y; Liu, S; Liu, X | 1 |
3 other study(ies) available for ampelopsin and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Astragalin and dihydromyricetin as adjuncts to histidine‑tryptophan‑ketoglutarate cardioplegia enhances protection during cardioplegic arrest.
Topics: Animals; Apoptosis; Biomarkers; Cardioplegic Solutions; Cardiotonic Agents; Cytokines; Disease Models, Animal; Flavonols; Glucose; Heart Arrest; Heart Arrest, Induced; Hemodynamics; Inflammation Mediators; Kaempferols; Male; Mannitol; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Potassium Chloride; Procaine; Rats; Recovery of Function; Ventricular Function | 2018 |
Dihydromyricetin Ameliorates Cardiac Ischemia/Reperfusion Injury through Sirt3 Activation.
Topics: Animals; Cardiotonic Agents; Cells, Cultured; DNA-Binding Proteins; Flavonols; High Mobility Group Proteins; Male; Mice; Mitochondria; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxygen; Sirtuin 3 | 2019 |
The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.
Topics: Animals; Apoptosis; Cardiotonic Agents; Flavonols; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2016 |